We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Rapid POC Diagnosis of Infectious Diseases

By HospiMedica International staff writers
Posted on 18 Mar 2015
New medical device technology that links biosensors to mobile phone apps could transform the way in which infectious diseases are diagnosed.

The OJ Bio is a hand-held, point of care (POC) diagnosis system that accurately and quickly identifies the presence of a range of disease biomarkers. More...
To use the system, staff must first collect a patient biological sample, such as serum, urine, saliva, or blood, which is then applied to a multichannel biochip placed into a disposable cartridge. The state-of-art biosensors are based on surface acoustic wave (SAW) electronic chips which are coated with disease-specific biocapture surfaces.

When the biosensor is slid into a proprietary specialist reading device, the presence of a specific disease antigen causes a shift in the phase angle of the SAW passing across the chip surface. The presence (or absence) of this shift provides an unequivocal pass-or-fail result for the particular disease being tested. Bluetooth connection of the reading device to special diagnostic software enables the test results to be displayed within seconds on a mobile phone app, a PC, or the device itself.

The platform allows the detection of any protein biomarkers, and can also be used to detect the presence of C-reactive protein (CRP, a biomarker of inflammatory disease), which can be used to rule out serious bacterial infections and which has therefore been proposed as a useful tool in the reduction of the inappropriate prescribing of antibiotics. Importantly, the diagnostic device can be used at a patient’s bed side or other POC locations. The OJ Bio system is a product of OJ Bio (Newcastle, United Kingdom).

“Our new device provides a low cost test that dramatically improves the speed of diagnosis and treatment that should hit the disease at source and limit its ability to spread,” said Dale Athey, CEO of OJ Bio. “The flexibility of the technology platform has wide ranging potential, not only for the detection and monitoring of human medical infections and conditions, but also for example in animal testing by veterinary practices.”

Research has so far focused on detection and diagnosis of the influenza A and B viruses, common flu strains previously linked to some major epidemics, and Respiratory Syncytial Virus (RSV), a major cause of coughs and chest infections. In addition, a number of other complementary projects are also underway to detect the presence of, for example, periodontal gum disease and HIV.

Related Links:

OJ Bio



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.